Business Market Insights | Chekout Form

Australia Lung Cancer Screening Market

Australia Lung Cancer Screening Market Forecast to 2030 – COVID-19 Impact and Country Analysis – By Cancer Type {Non–Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer}, Technology {Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others}, Age group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

Single User

For the basics

50% Discount

$3450

$1725

BUY NOW

Single user report accessibility
Free 10% customization
Free post-sale assistance
PDF deliverable

Best Seller

Site User

For the premium

50% Discount

$4450

$2225

BUY NOW

Multi-user accessibility within one corporate location
Free 10% customization
Free post-sale assistance
PDF deliverable
Dedicated account manager
Permission to print the report

Enterprise User

For the professional

50% Discount

$5450

$2725

BUY NOW

Corporate wide accessibility
Free 10% customization
Free post-sale assistance
Excel & PDF deliverables
Dedicated account manager
Permission to print the report

Our Clients

Mundipharma International Limited.png

Philips Healthcare.png

Rockwell Collins.png

Business Market Insights

E 1803, Panchshil Towers, Wagholi, Haveli,
Pune - 412207, Maharashtra, India

US:+1 646 791 7070

sales@businessmarketinsights.com

Useful Links

Terms & Conditions

Cancellation / Refund Policy

Our Services

Syndicate Research

Custom Research

paypal

© 2026 Business Market Insights. All Rights Reserved.